Amylin, a neuroendocrine hormone co-released with insulin, controls hunger, gastric motility, glucagon secretion, and energy metabolism via divergent amylin receptor (AMYR) subtypes (1-3), namely the calcitonin receptor (CTR) and the receptor activity-modifying proteins (RAMPs)
By systematically reviewing the neurotoxic mechanisms, clinical manifestations, and therapeutic interventions associated with these six drugs, this study aims to provide insights into the current knowledge gaps and potential avenues for future research
To view a copy of this licence, visit About this article Cite this article Li, H., Wen, H., Liu, J
NAD+ Dynamics
By combining two of the most widely studied peptides in regenerative science, this formulation offers researchers a unique opportunity to examine synergistic mechanisms of repair and protection across multiple biological systems
Pediatric B12 Dosing Guidelines Kids need special attention when it comes to B12 doses